Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children
Clinical trial NCT02263131 · COMPLETED
Trial details
- NCT number
- NCT02263131
- Sponsor
- Il-Yang Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.